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Introduction
Hematopoietic stem cells give rise to committed myeloid progenitors (granulocyte-monocyte colony forming units [CFU- C]),' which in turn differentiate into mature granulocytes and Receivedfor publication 24 August 1984.
1. Abbreviations used in this paper: CFU-C, granulocyte-monocyte colony forming units; endo H, endo-#-N-acetylglucosaminidase H; FCS, fetal calf serum; HAT, hypoxanthine/aminopterin/thymidine medium; tk, thymidine kinase. monocytes (1, 2) . Monoclonal antibodies that bind to epitopes of surface molecules expressed by subsets of cells within the human granulocytic and monocytic series also react with malignant cells from patients with myeloid leukemias, which suggests that the tumor cells represent clonal derivatives of myeloid progenitors blocked in various stages of differentiation (3) . In a recent international workshop, a strong concordance of reactivity with both normal and malignant myeloid cells was demonstrated for three monoclonal antibodies: MY7, DU-HL60-4, and MCS.2 (4) . The antibodies DU-HL60-4 and MY7 precipitate glycoproteins with molecular weights of -150,000 (5, 6) , which suggested that they could recognize epitopes on the same cell surface glycoprotein. Both DU-HL60-4 and MY7 exhibit a panmyeloid pattern of reactivity, marked by binding to subsets of human CFU-C and normal granulocytic and monocytic cells at various stages of differentiation (3-7). All three antibodies bind to the human promyelocytic leukemia cell line HL-60 and to leukemic cells from '80% of patients with myeloid leukemia (3) (4) (5) (6) (7) . In contrast, these antibodies do not bind to human lymphoid leukemia cells, normal B or T lymphocytes, platelets, erythrocytes, or erythroid progenitors defined by burst-forming units or colonyforming units (3) (4) (5) (6) (7) . Despite extensive study of the pattern of reactivity of these antibodies with cells during myeloid differentiation, the function of the cell surface glycoprotein they identify is not known.
DNA-mediated transfer of genes encoding molecules expressed on the cell surface provides a powerful approach for isolating such genes and studying their regulation and expression. By cotransfection of mouse L cells deficient in thymidine kinase (tk) with the herpes simplex virus tk gene, together with DNA from a human T cell leukemia cell line, stable transformants that expressed human HLA class I, 32-microglobulin, and T cell differentiation antigens were obtained (8) . The small proportions of transformants expressing these antigens were isolated with a fluorescence-activated cell sorter. The same strategy was recently used to isolate and clone the human transferrin receptor gene (9) . We have applied a similar approach to isolate mouse fibroblasts expressing the human myeloid cell membrane glycoprotein gpl50. Independently transformed mouse cell clones were found to contain a characteristic, limited subset of human DNA sequences and to express gpl 50 molecules precipitable with DU-HL60-4, MY7, and MCS.2 monoclonal antibodies. Hence, the epitopes recognized by these antibodies are represented on the product of a single human gene.
(100 Ag/ml). The human promyelocytic cell line, HL-60 (12) , was maintained in RPMI 1640 medium containing 12.5% FCS and antibiotics. Transformed L cells were grown in selective media (HAT) containing hypoxanthine (100 MM), aminopterin (0.4 uM), and thymidine (16 WM) . Transformed NIH/3T3 cells were cultured in medium containing 5% FCS.
Preparation of cellular DNAs. Confluent flasks of cells growing as monolayers were washed in phosphate-buffered saline (PBS) and lysed in the flask with 40 ml of 10 mM Tris-HCI, pH 7.4, 10 mM EDTA, 50 ,g/ml RNAse, 100 Mg/ml proteinase K, and 1% sodium dodecyl sulfate (SDS). HL-60 cells growing in suspension were pelleted by centrifugation at 1500 rpm for 5 min, washed in PBS, and added to the same lysis buffer. After incubation for 4 h at 370C, nucleic acids were repeatedly extracted with an equal volume of Tris-HCl (pH 8.0) saturated phenol until a clear interphase was obtained. The aqueous phase was then extracted with an equal volume of phenol, chloroform, and isoamyl alcohol (25:24:1), and once with an equal volume of chloroform and isoamyl alcohol (24:1). NaCl was added to a final concentration of 0.2 M, and the DNA was precipitated with 2 vol cold 100% ethanol and spooled onto a glass rod. Dried precipitates were resuspended in 10 mM Tris-HCl and I mM EDTA, pH 7.4, at 200-500 Mg/ml and dialyzed against the same solution. (17) The cells were washed twice with PBS before lysis. Immunoprecipitation and electrophoretic analysis were carried out as described above.
Enzymatic digestions of immunoprecipitates. Metabolically labeled glycoproteins were immunoprecipitated, and the precipitates were washed five times in lysis buffer and three more times in lysis buffer lacking SDS and EDTA. The precipitates were divided and incubated for 20 h at 37°C in 20 Al of either (a) 0.3 U of Streptomyces griseus endo-p-N-acetylglucosaminidase H (endo H) (EC 3.2.1.96) (Sigma Chemical Co.) per ml in 150 mM sodium citrate (pH 5.3); or (b) 1.0 U of Vibrio cholerae neuraminidase (EC 3.2.1.18) (Calbiochem-Behring Corp., American Hoechst Corp., San Diego, CA) per ml in 50 mM sodium acetate (pH 5.5) containing 150 mM NaCI and 4 mM CaCl2. Parallel control incubations were performed by use of the indicated buffer solutions without enzymes. Reactions were terminated by the addition of 40 Ml gel sample buffer and heating to 100°C for 2 min before loading onto gels.
Peptide mapping. Metabolically labeled polypeptides in polyacrylamide gel slices were oxidized with performic acid and digested in L-(tosylamido-2-phenyl) ethyl chloromethyl ketone-treated trypsin as described (35) . Eluted peptides were separated in two dimensions on cellulose-coated, thin layer plates (20 X 20 cm; E. Merck, Darmstadt, Germany) by electrophoresis at 1,000 V for 20 min in acetic acidformic acid-water (15:5:80, pH 1.9), followed by ascending chromatography in 1-butanol-pyridine-acetic acid-water (65:50:10:40) containing 7% (wt/vol) diphenyloxazole. Dried plates were exposed to Kodak XAR-5 film (Eastman Kodak Co., Rochester, NY) for fluorography.
Results
Strategy for DNA-mediated gene transfer. The uptake of high molecular weight DNA precipitates by transfected mouse cell lines, such as L cells or NIH/3T3 cells, leads to stable incorporation of the donor DNA in <0.1% of the recipient cells (14, 15). Despite the low efficiency of transformation, cotransfection of two unlinked genes leads in general to incorporation of both genetic markers in at least one half of the successfully transformed population. Hence, dominant selectable markers can be used to obtain cells that have acquired exogenous DNA, among which at least 50% should express other donor (18, 19) .
Individual libraries of mouse cells cotransfected with HL-60 DNA were grown and selected by fluorescence-activated cell sorting for the presence of cells reacting with the monoclonal antibodies DU-HL60-4, MY7, and SJ-DI (Fig. 1) . After 2% of cells with the brightest fluorescence were sorted, grown up, and resorted through from three to five successive rounds, cell populations were obtained that were >80% reactive with each monoclonal antibody by immunofluorescence analysis. Eleven individual positive cell populations were obtained with each of three monoclonal antibodies from libraries generated with both the tk and v-fms selection systems. When tested for reactivity with a panel of human myeloid differentiationspecific monoclonal antibodies (Table I) , each of the independently sorted cell populations was positive by immunofluorescence with DU-HL60-4, MY7, SJ-D1, and MCS.2 antibodies, regardless of which antibody was used for the selection (Fig.  1) . By contrast, negative fluorescence profiles identical to those obtained with control myeloma proteins were obtained with other monoclonal antibodies specific for human myeloid antigens (Table I) or human histocompatibility class I (W6/32) and class 11 (2) framework determinants. As additional controls, two of the transfected L cell libraries were sorted with the monoclonal antibody W6/32 specific for human class I histocompatibility antigens (8) . After three successive rounds of sorting, positive cell populations expressing HLA gene products were obtained. These cells did not react with any of the panel of monoclonal antibodies specific for human myeloid antigens (Table I) .
To enrich for DNA sequences encoding human myeloid differentiation antigens, a series of secondary transformants was selected. DNA was extracted from three different L cell populations that had been independently selected for reactivity with the monoclonal antibodies DU-HL60-4, MY7, and SJDl. These DNAs were cotransfected with selectable markers into L (tk-) cells or NIH/3T3 cells (Table II) (Fig. 2) . Hence, the concordance of reactivities of transformed cells with four monoclonal antibodies was independent of the selective system used for DNA-mediated gene transfer, did not depend on which of the monoclonal antibodies was used in cell selection, and was observed after serial rounds of DNA-mediated gene transfer.
Cells expressing myeloid antigens contain human DNA. The cellular DNAs of primary transformants and cloned secondary transformants from independent transfection experiments were analyzed by Southern blotting for the presence of restriction fragments hybridizing to a radiolabeled probe prepared from human repetitive DNA sequences. We reasoned that the secondary transformants would contain only a limited subset of human DNA sequences, so that human DNA restriction fragments shared between the DNAs of independently derived clones would be those that encode the myeloid antigens.
Most human DNA fragments, regardless of their coding sequences, would be expected to contain members of highly reiterated sequence families that would anneal to the probe, whereas mouse DNA would not anneal to the probe under stringent hybridization conditions. A similar approach was used to demonstrate human transforming gene sequences transfected into mouse NIH/3T3 cells (compare reference 18). (5, 6) to react with glycoproteins of apparent molecular weights of 150,000. Fig. 4 (Table I ). Polypeptides similar to those precipitated from HL-60 cells were also recovered from metabolically labeled lysates of secondary mouse cell transformants (see Fig. 4 HL-60 cells rendered indistinguishable tryptic fingerprints. The identity ofthe individual peptides was confirmed by experiments in which the two labeled products were mixed before analysis (data not shown). An identical tryptic fingerprint was also generated with gpl 30 expressed by a transformed NIH/3T3 subclone (C). Again, a mixing experiment confirmed that the molecules expressed in donor HL60 and recipient mouse cells were indistinguishable (D). These results demonstrate that gpl 30 and gpl 50 are related at the level of amino acid sequence and argue that the proteins expressed in the mouse secondary transformants are the products of a human gene.
The above results also suggested that gpl 30 and gpl 50 represented alternative, post-translationally modified forms of the same gene product. Kinetic experiments shown in Fig.  6 A indeed demonstrated that gpl30 is a precursor to gpl50. When HL-60 cells were pulse-labeled for 15 min with [35S~methionine, only gpl30 molecules were detected. During incubation in the presence of nonradioactive methionine for various intervals, gp130 molecules were completely converted to gpl50 molecules. Both forms of the antigen were detected after 60 min of incubation, and by 120 min, most molecules were processed to the gpl 50 form. Fig. 6 Fig. 4 , lanes 3 and 5) probably reflects differences in the composition of the complex oligosaccharide chains synthesized in the two cell types.
These data suggested that gp150 molecules, processed in the Golgi complex, represent the cell surface form of the glycoprotein. To define the nature of the molecules on the plasma membrane, viable HL-60 cells were radioiodinated with lactoperoxidase, and detergent lysates were immunoprecipitated by use of the monoclonal antibody DU-HL60-4. Fig.   576 Look et al. yielded secondary mouse cell transformants that contained a limited subset of human DNA sequences shared by independently derived subclones. The secondary subclones synthesized two specifically precipitable glycoprotein molecules (gpl 30 and gpl50), which were also detected with the same monoclonal antibodies in parental HL-60 donor cells. Kinetic and biochemical experiments showed that gpl30 was a precursor of gpl 50, differing from the cell surface form of the glycoprotein in the composition of its N-linked oligosaccharide chains. A comparison of the [35S]methionine-labeled tryptic cleavage products of gpl30 and gpl50 molecules from human and mouse cells showed unequivocally that these polypeptides are the product of the same gene. We conclude that the mobilized human DNA sequences in secondary transformants encode gpl 30 and gpl 50 and provide the first direct evidence that the monoclonal antibodies DU-HL604, MY7, MCS.2, and SJ-Dl react with epitopes on a single glycoprotein. These results are consistent with previous observations that these four monoclonal antibodies react with similar subsets of normal and malignant human myeloid cells (3) (4) (5) (6) (7) 20) .
The pattern of expression of gplSO by cells in the human myeloid lineage is based primarily on studies with the monoclonal antibodies DU-HL60-4 (5, 7) and MY7 (3, 6, 39) . gpl 50 has a panmyeloid distribution, since it can be identified on normal marrow granulocytic and monocytic cells at all recognizable levels of differentiation. The molecule is unusual in its expression, in that it is detectable only on a fraction of cells at each stage of differentiation, in contrast to most differentiation-specific antigens, which tend to be uniformly expressed by cells of a given morphologic type (39) . gpl 50 is also expressed by a subset of human CFU-C, with preferential expression in regenerating marrow and in cells in the DNA synthesis phase of the cell cycle. Based on increased expression of the molecule by progenitors engaged in cell division, Griffin et al. (39) proposed that gpl 50 could be analogous to certain cell surface glycoproteins of lymphocytes that are present at low levels on resting cells but are induced by mitogenic stimulation. The elaboration of gpl 50 by human myeloid leukemia cells but not by lymphoid tumors has led to the use of monoclonal antibodies to gpl50 as diagnostic tools. Whether the expression of gpl 50 has any relation to the process of malignant transformation in myeloid leukemia remains unclear. The selective expression of gpl 50 by proliferative human granulocyte-monocyte progenitors and by their leukemic derivatives raises the possibility that the glycoprotein might function to influence the proliferative capacity of myeloid cells.
Studies with the monoclonal antibody DU-HL604 also demonstrated antigen in sections of renal tissue in proximal tubules and Bowman's capsules and in testicular cells (5 (9) . In principle, the construction of a genomic DNA library by use of secondary transformants, and probing of the library for human repetitive DNA sequences should allow portions of the gene to be readily cloned. Since the cloned genes would similarly be expected to be expressed in mouse cell recipients, DNA-mediated gene transfer can be used to verify the functional integrity of the cloned sequences. The approach should be generally applicable to genes encoding cell surface antigens expressed on normal or malignant cells, including antigens expressed in fresh tissues from patients.
